Dupilumab Study

By |2021-10-19T03:16:46-07:00March 22nd, 2017|Dupilumab, RSS Patients|

The following are comments by Marvin Rapaport MD, owner of this website, Red Skin Syndrome, and edited and clearly written by an esteemed writer and journalist, Ruchy Reese, who writes for the monthly magazine, Wellspring.   I am writing in response to an article that appeared in the December 15, 2016 edition of the New [...]

Comments Off on Dupilumab Study

Letter to Editor of JAAD

By |2021-10-19T03:16:47-07:00November 30th, 2016|Dupilumab, Topical Steroid Withdrawal|

  November 17, 2016   Bruce H. Thiers, MD c/o Detra Davis, Managing Editor Journal of the American Academy of Dermatology 930 E Woodfield Rd Schaumburg, IL 60173   Dear Dr. Thiers: Please review the two enclosed “letters to the Editor” with an open mind. I am appealing to your scientific nature as a doctor [...]

Comments Off on Letter to Editor of JAAD

Ethics in Drug Studies

By |2019-12-12T18:13:56-08:00November 30th, 2016|Dupilumab, RSS Patients|

November 17, 2016 Bruce H. Thiers, MD c/o Detra Davis, Managing Editor Journal of the American Academy of Dermatology 930 E. Woodfield Rd Schaumburg, IL 60173   Re: Ethics in Drug Studies To the Editor:   Dupilumab (JAAD 2016, 75; 506-516) by Simpson et al has three glaring ethical concerns: Protocol: There is no mention [...]

Comments Off on Ethics in Drug Studies
Go to Top